ArticleJournal of clinical microbiology2011
Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.
Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).Hepatology (Baltimore, Md.) · 2016Trial
- Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.Virology journal · 2014Trial
- Review
- Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011-2020.JGH open : an open access journal of gastroenterology and hepatology · 2024Article
- The Changing Epidemiology of Hepatitis C Virus Acquisition Among HIV-Infected Individuals in Brazil.AIDS research and human retroviruses · 2023Observational
- Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention.Seminars in dialysis · 2019Review
- Review
- Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.Journal of clinical gastroenterology · 2019Observational
- Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes.Medical decision making : an international journal of the Society for Medical Decision Making · 2018Article
- Patient Characteristics and Prescribing Patterns Associated with Sofosbuvir Treatment for Chronic HCV Infection in a Commercially Insured Population.American health & drug benefits · 2016Article
- Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China.SpringerPlus · 2016Article
- Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission.BMC research notes · 2015Article
- Factors Associated with Failure to Achieve SVR in Hepatitis C Genotype 3 Patients Within an Integrated Care Delivery System.Journal of managed care & specialty pharmacy · 2015Article
- Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C.Therapeutic advances in chronic disease · 2015Review
- Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.Antimicrobial agents and chemotherapy · 2014Article
- Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Current HIV/AIDS reports · 2013Review
- Hepatitis C virus genotypes in north eastern Algeria: A retrospective study.World journal of hepatology · 2013Article
- Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.Immunologic research · 2012Review
- Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.BMC infectious diseases · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis C virus (HCV) genotype (GT) distribution and frequency were studied among 22,407 unique specimens tested at a national reference testing laboratory. Subjects with HCV GT 3 were younger (P < 0.0001) than those with GT 1, 2, or 4, and the regional frequencies of HCV GT 2 and 3 ranged from 19.9% to 29.2%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.